Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
84.80
-0.79 (-0.92%)
May 14, 2026, 11:38 AM EDT - Market open
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $6.98 billion as of May 14, 2026. Its market cap has increased by 217.96% in one year.
Market Cap
6.98B
Enterprise Value
5.49B
1-Year Change
217.96%
Ranking
Category
Stock Price
$84.80
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $6.98B, an increase of 735.90%. That is a compound annual growth rate of 44.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 7.04B | 13.10% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 7.87B |
| Vaxcyte | 7.80B |
| Bio-Techne | 7.42B |
| Protagonist Therapeutics | 6.66B |
| Spyre Therapeutics | 6.64B |
| Mirum Pharmaceuticals | 6.47B |
| PTC Therapeutics | 6.37B |
| Apogee Therapeutics | 6.34B |